Search

everythinglearnresearchcommunity

for

Search:↓

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Krox20 overexpression in fibroblasts may play a role in abnormal scar formation and could be a target for new treatments.

Glycyrrhiza glabra extract may prevent hair loss like finasteride.

Semaglutide may worsen eating disorders in vulnerable individuals.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

New treatments for common hair loss are needed.

Certain astrocytes can protect the brain and improve recovery after a stroke, and a hair loss drug might reduce cancer spread.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Gymnema sylvestre leaf extract can slow hair growth.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

PLGA-based microneedles show promise for painless, long-term drug delivery but need design and safety improvements.

Hair straightening products with glyoxylic acid can cause skin irritation and kidney damage.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Dystonia may be part of PAS-4 and linked to immune issues.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

Ginsenoside Rg4 from ginseng may help hair growth by activating certain cell signals.

The document concludes that treatment improved skin lesions but not scalp hair loss in two patients with Graham-Little-Piccardi-Lassueur syndrome.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

A quick method effectively detects banned substances in urine.